Literature DB >> 29519862

and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.

Michael Asger Andersen1, Casper Tabassum Eriksen1, Christian Brieghel1, Jorne Lionel Biccler2, Caspar da Cunha-Bang1, Marie Helleberg3, Carsten Utoft Niemann4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29519862      PMCID： PMC6029543          DOI： 10.3324/haematol.2017.182006

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

Review 1.  Competing risks in epidemiology: possibilities and pitfalls.

Authors:  Per Kragh Andersen; Ronald B Geskus; Theo de Witte; Hein Putter
Journal:  Int J Epidemiol       Date:  2012-01-09       Impact factor: 7.196

2.  Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.

Authors:  J Moreira; K G Rabe; J R Cerhan; N E Kay; J W Wilson; T G Call; J F Leis; D F Jelinek; S M Schwager; D A Bowen; C A Hanson; S L Slager; T D Shanafelt
Journal:  Leukemia       Date:  2012-07-11       Impact factor: 11.528

3.  Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance.

Authors:  C Rozman; E Montserrat; N Viñolas
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

4.  The CLL-IPI applied in a population-based cohort.

Authors:  Caspar da Cunha-Bang; Ilse Christiansen; Carsten Utoft Niemann
Journal:  Blood       Date:  2016-09-07       Impact factor: 22.113

5.  Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.

Authors:  Michael Asger Andersen; Fie Juhl Vojdeman; Mette Klarskov Andersen; Peter de Nully Brown; Christian Hartmann Geisler; Ole Weis Bjerrum; Carsten Utoft Niemann
Journal:  Leuk Lymphoma       Date:  2016-02-05

6.  Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Clare Sun; Xin Tian; Yuh Shan Lee; Sreenivasulu Gunti; Andrew Lipsky; Sarah E M Herman; Dalia Salem; Maryalice Stetler-Stevenson; Constance Yuan; Lela Kardava; Susan Moir; Irina Maric; Janet Valdez; Susan Soto; Gerald E Marti; Mohammed Z Farooqui; Abner L Notkins; Adrian Wiestner; Georg Aue
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113

Review 7.  Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.

Authors:  Vicki A Morrison
Journal:  Clin Lymphoma Myeloma       Date:  2009-10

8.  Long-term survival following bacteremia or fungemia.

Authors:  L Leibovici; Z Samra; H Konigsberger; M Drucker; S Ashkenazi; S D Pitlik
Journal:  JAMA       Date:  1995-09-13       Impact factor: 56.272

Review 9.  Selective IgA deficiency.

Authors:  Leman Yel
Journal:  J Clin Immunol       Date:  2010-01-26       Impact factor: 8.317

Review 10.  The Danish National Chronic Lymphocytic Leukemia Registry.

Authors:  Caspar da Cunha-Bang; Christian Hartmann Geisler; Lisbeth Enggaard; Christian Bjørn Poulsen; Peter de Nully Brown; Henrik Frederiksen; Olav Jonas Bergmann; Elisa Jacobsen Pulczynski; Robert Schou Pedersen; Linda Højberg Nielsen; Ilse Christiansen; Carsten Utoft Niemann
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790
View more
  11 in total

1.  Immune failure, infection and survival in chronic lymphocytic leukemia.

Authors:  Kyle R Crassini; O Giles Best; Stephen P Mulligan
Journal:  Haematologica       Date:  2018-07       Impact factor: 9.941

2.  Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark.

Authors:  Michael Asger Andersen; Carsten Utoft Niemann
Journal:  Haematologica       Date:  2018-07       Impact factor: 9.941

3.  IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.

Authors:  Ganchimeg Ishdorj; Erin Streu; Pascal Lambert; Harbhajan S Dhaliwal; Salaheddin M Mahmud; Spencer B Gibson; Versha Banerji; Aaron J Marshall; James B Johnston
Journal:  Blood Adv       Date:  2019-07-23

4.  Pyomyositis presenting as myonecrosis secondary to methicillin-resistant Staphylococcus aureus bacteremia in chronic lymphocytic leukemia.

Authors:  Shannon Coombs; Albert Bui; Haares S Mirzan; Kimberly Robelin; Hillary W Garner; Murli Krishna; Jennifer B Cowart
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-31

5.  Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.

Authors:  Yandong Shen; Luke Coyle; Ian Kerridge; William Stevenson; Christopher Arthur; Naomi McKinlay; Keith Fay; Christopher Ward; Matthew Greenwood; Oliver Giles Best; Ann Solterbeck; Alexander Guminski; Stephen Shumack; Stephen P Mulligan
Journal:  EJHaem       Date:  2021-12-13

6.  The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial.

Authors:  Monica Else; Stuart J Blakemore; Jonathan C Strefford; Daniel Catovsky
Journal:  Leukemia       Date:  2021-02-12       Impact factor: 11.528

7.  Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia.

Authors:  Emelie C Rotbain; Klaus Rostgaard; Michael A Andersen; Caspar Da Cunha-Bang; Carsten U Niemann; Henrik Frederiksen; Henrik Hjalgrim
Journal:  Clin Epidemiol       Date:  2021-12-30       Impact factor: 4.790

8.  Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.

Authors:  Hartmut Link; Markus Kerkmann; Laura Holtmann
Journal:  Support Care Cancer       Date:  2022-03-07       Impact factor: 3.359

9.  Machine learning can identify newly diagnosed patients with CLL at high risk of infection.

Authors:  Rudi Agius; Christian Brieghel; Michael A Andersen; Alexander T Pearson; Bruno Ledergerber; Alessandro Cozzi-Lepri; Yoram Louzoun; Christen L Andersen; Jacob Bergstedt; Jakob H von Stemann; Mette Jørgensen; Man-Hung Eric Tang; Magnus Fontes; Jasmin Bahlo; Carmen D Herling; Michael Hallek; Jens Lundgren; Cameron Ross MacPherson; Jan Larsen; Carsten U Niemann
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

10.  Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases.

Authors:  Josefine Nordvig; Theis Aagaard; Gedske Daugaard; Peter Brown; Henrik Sengeløv; Jens Lundgren; Marie Helleberg
Journal:  Open Forum Infect Dis       Date:  2018-10-25       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.